WiTii Pharmaceuticals, Inc. — Form D
WiTii Pharmaceuticals, Inc. of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-11. The offering totals $500K, of which $125K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-07-11
- Form: D
- Accession: 0002029215-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $125K
- Remaining: $375K
- Investors: 2
- Date of first sale: 2024-06-21
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-518357
Issuer
- Name: WiTii Pharmaceuticals, Inc.
- CIK: 0002029215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1499 W. 120TH AVENUE, DENVER, CO, 80234
- Phone: 720-469-0635
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Sreejayan Nair | Director | Denver, CO |
| Anand Shukla | Director | Denver, CO |
| Anand Shukla | Executive Officer | Denver, CO |
| Anand Shukla | Promoter | Denver, CO |
More